Gilead Wins Reversal of $2.54 Billion Hepatitis C Drug Patent Verdict
Gilead Wins Reversal of $2.54 Billion Hepatitis C Drug Patent Verdict P&T Community US judge overturns Gilead $2.54bn patent infringement ruling pharmaphorum US court voids $2.5 billion verdict in Gilead/Merck patent dispute The Pharma Letter Full coverage